Helping cancer patients share medication experiences during care changes
Patient Engagement in Reporting Medication Events during Transitions of Care
This project aims to create a user-friendly platform where cancer patients and their families can easily report medication concerns when moving between different care settings, especially for those taking oral cancer medicines at home.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project ID | NIH-11091609 on NIH RePORTER |
What this research studies
When cancer patients move between different care settings, like going home from the hospital, managing medications can be tricky and sometimes risky. This project is developing a special online tool to help patients and their families easily share any medication issues or side effects they experience during these transitions. The goal is to better understand what causes these problems, especially for those taking complex oral cancer drugs at home, so that care can be made safer and more effective. By giving patients a voice, we hope to improve how medication safety is managed and supported.
Who could benefit from this research
Good fit: Ideal candidates are cancer patients taking oral anticancer agents at home who are experiencing transitions in their care.
Not a fit: Patients not undergoing cancer treatment, not taking oral anticancer agents, or not experiencing care transitions would likely not directly benefit from this specific platform.
Why it matters
Potential benefit: If successful, this platform could lead to safer medication use and better support for cancer patients managing their treatments at home, reducing the risk of adverse events.
How similar studies have performed: While the idea of patient-reported safety has shown promise, this project focuses on how to best engage patients and families in using such reporting systems, which is an area that needs more understanding.
Where this research is happening
Ann Arbor, United States
- University of Michigan at Ann Arbor — Ann Arbor, United States (Active)
Researchers
- Principal investigator: Jiang, Yun — University of Michigan at Ann Arbor
- Study coordinator: Jiang, Yun
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.